Table 1 Genes Dys-regulated in TG Mice vs WT Controls Five Days After DOX-treatment.
Upregulated (Fold Increase) | Downregulated (Fold Increase) |
---|---|
Apoptosis | |
Btg2 (2.67) | Lcn2 (2.27) |
Phlda3 (2.52) | Hmox1 (2.04) |
Dnase2a (2.11) | Plscr1 (1.72) |
Asns (2.09) | Mical1 (1.72) |
Mmp2 (2.08) | Nr4a1 (1.67) |
Cxcl12 (2.05) | Zfp110 (1.61) |
Sh3kbp1 (1.99) | Malt1 (1.56) |
Igf1 (1.85) | Bcl2l1 (1.54) |
Slit2 (1.78) | Mknk2 (1.54) |
Chac1 (1.75) | Ntn1 (1.54) |
Pla2g4a (1.73) | Casp9 (1.52) |
Aen (1.72) | Dapk1 (1.52) |
Bcl2 (1.62) | Xrcc5 (1.52) |
Sfrp1 (1.62) | Bik (1.52) |
Ccng1 (1.60) | Â |
Grk5 (1.59) | Â |
Ptgfr (1.58) | Â |
Fhl2 (1.57) | Â |
Atf5 (1.57) | Â |
Pf4 (1.56) | Â |
Cycs (1.55) | Â |
Extracellular matrix and/or genes associated with fibrosis | |
Postn (3.17) | Cyr61 (3.57) |
Col3a1 (2.76) | Ctgf (1.96) |
Olfml2b (2.62) | Spock2 (1.52) |
Lgals3 (2.55) | Â |
Sulf2 (1.79) | Â |
Col1a2 (1.73) | Â |
Smoc2 (1.69) | Â |
Col5a2 (1.67) | Â |
Egflam (1.64) | Â |
Col1a2 (1.64) | Â |
Col1a1 (1.53) | Â |
Crispld2 (1.50) | Â |
Col5a1 (1.50) | Â |
Ndufs4 (1.50) | Â |
Cell growth/proliferation | |
Cxcl12 (2.05) | Tacc2 (1.72) |
Nppa (1.87) | Bcl2l1 (1.54) |
Slit2 (1.78) | Xrcc5 (1.52) |
Pla2g4a (1.73) | Â |
Myocd (1.63) | Â |
Sfrp1 (1.62) | Â |
Bcl2 (1.62) | Â |
Fanca (1.62) | Â |
Atf5 (1.57) | Â |
Emp1 (1.53) | Â |
Serpine2 (1.52) | Â |
Nf2 (1.52) | Â |
Cgrrf1 (1.50) | Â |
Heart development/embryonic skeletal system development/actin cytoskeleton organization/multicellular organismal development | |
Wif1 (2.47) | Sorbs1 (1.82) |
Dnase2a (2.11) | Enah (1.67) |
Eda2r (2.04) | Dmd (1.61) |
Pdlim7 (1.89) | Vamp5 (1.59) |
Sulf2 (1.79) | Flnb (1.56) |
Slit2 (1.78) | Â |
Sema3c (1.74) | Â |
Myocd (1.63) | Â |
Sfrp1 (1.62) | Â |
Bves (1.61) | Â |
Ptpla (1.60) | Â |
Cap1 (1.54) | Â |
Sema3b (1.54) | Â |
Col1a1 (1.53) | Â |
Nf2 (1.52) | Â |
Serpine2 (1.52) | Â |
Hypertrophy | |
Igf1 (1.85) | Lmcd1 (1.67) |
Immune/inflammatory response | |
Clec4n (2.14) | Plscr1 (1.89) |
Cxcl12 (2.05) | Cblb (1.61) |
Ccl8 (1.93) | Â |
Slit2 (1.78) | Â |
Ccl12 (1.71) | Â |
Ly96 (1.67) | Â |
C3ar1 (1.58) | Â |
Ccl6 (1.57) | Â |
Pf4 (1.56) | Â |
Ccl9 (1.5) | Â |
Oxidation-reduction process | |
Cyp2b10 (4.00) | Cp (2.17) |
Mthfd2 (3.13) | Fmo2 (1.92) |
Pam (1.90) | Fdft1 (1.82) |
Aldh1l2 (1.74) | Mical1 (1.72) |
Asph (1.73) | D2hgdh (1.67) |
Loxl2 (1.69) | Cyp2d22 (1.64) |
Loxl1 (1.67) | P4htm (1.64) |
Aldh18a1 (1.60) | Dmd (1.61) |
Mecr (1.59) | Gpd1 (1.61) |
Nqo2 (1.54) | Vamp5 (1.59) |
Hsd17b7 (1.52) | Hsd17b10 (1.59) |
Ndufs4 (1.50) | Bckdhb (1.56) |
 | Glrx3 (1.56) |
 | Cat (1.54) |
 | Fmo5 (1.52) |
 | Tet2 (1.52) |